Efficacy and Safety of Trastuzumab Duocarmazine in Pretreated Patients With HER2+ Advanced or Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
J. Clin. Oncol 2024 Oct 23;[EPub Ahead of Print], N Turner, C Saura, P Aftimos, E van den Tweel, M Oesterholt, N Koper, M Colleoni, E Kaczmarek, K Punie, X Song, A Armstrong, G Bianchi, A Stradella, S Ladoire, JSJ Lim, N Quenel-Tueux, TJ Tan, S Escrivá-de-Romaní, J O'ShaughnessyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.